GastroenterologyNews.net

Gastroenterology Xagena

Search results for "Gastroesophageal junction adenocarcinoma"

The FDA ( Food and Drug Administration ) has approved Ramucirumab ( Cyramza ) in combination with Paclitaxel as a treatment for people with advanced or metastatic gastric or gastroesophageal junction ...